CEO Keith Gottesdiener will be replaced by Prime's CFO as the company cuts 25% of its workforce and deprioritizes its lead ...

Faeth Therapeutics, a clinical-stage biotechnology company integrating precision nutrition with combination therapies to ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for its novel ...

according to Phase I trial data reported by researchers at The University of Texas MD Anderson Cancer Center. The results were presented today in the clinical trials plenary session at the ...

Explore Jaguar Health's Q1 2025 earnings insights, featuring groundbreaking proof-of-concept data, regulatory advancements, and strategies ...

PT-112 monotherapy advances to phase 3 trial in metastatic castration-resistant prostate cancer after positive FDA end of ...

“These are encouraging early clinical data, especially because this ... to establish the optimal recommended dose for a future Phase II trial. This trial was funded by Roche.

Autonomix Medical, Inc. has announced its plans to commence a follow-on phase of its proof-of-concept clinical trial, known as PoC 2, which is set to begin in Q2 2025. This phase will further ...

Now, a new study combining data from two separate phase 1 clinical trials shows ... "These trials provide proof of concept for a stepwise approach to elicit custom-tailored responses -- not ...

Despite Merck KGaA’s lupus drug failing to prove itself against one form of the autoimmune disease, the German drugmaker has ...

Results further validate PlaCCine as a novel vaccine platform with potential applications in COVID-19 and other infectious diseases with epidemic implications “It is very encouraging to see strong ...